PRAME and WT1 transcripts constitute a good molecular marker combination for monitoring minimal residual disease in myelodysplastic syndromes. - Qin, Ya-Zhen; Zhu, Hong-Hu; Liu, Yan-Rong; Wang, Ya-Zhe; Shi, Hong-Xia; Lai, Yue-Yun; Xu, Lan-Ping; Liu, Dai-Hong; Jiang, Qian; Li, Ling-Di; Jiang, Bin; Liu, Kai-Yan; et al. (Leukemia & Lymphoma, 2013)